The potential of circHIPK3 as a biomarker in chronic myeloid leukemia
Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by leukocytosis and left shift. The primary molecular alteration is the BCR::ABL1, chimeric oncoprotein with tyrosine kinase activity, responsible for the initial oncogenesis of the disease. Therapy of CML was revolutioniz...
Main Authors: | Eduardo Wandame Gomez, Laura Berti De Paula, Rafael Diogo Weimer, Alessandra Helena da Silva Hellwig, Grazielle Motta Rodrigues, Ana Paula Alegretti, Jarbas Rodrigues de Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1330592/full |
Similar Items
-
The Diagnostic and Therapeutic Role of Circular RNA HIPK3 in Human Diseases
by: Yanfei Feng, et al.
Published: (2022-10-01) -
<i>Sp1</i>-Mediated circRNA <i>circHipk2</i> Regulates Myogenesis by Targeting Ribosomal Protein Rpl7
by: Junyu Yan, et al.
Published: (2021-05-01) -
Exosomal circHIPK3 derived from umbilical cord‐derived mesenchymal stem cells enhances skin fibroblast autophagy by blocking miR‐20b‐5p/ULK1/Atg13 axis
by: Zhi‐Yang Qiu, et al.
Published: (2023-12-01) -
The Glioblastoma CircularRNAome
by: Alexandru Tirpe, et al.
Published: (2023-09-01) -
CircHIPK3 relieves vascular calcification via mediating SIRT1/PGC-1α/MFN2 pathway by interacting with FUS
by: Siyi Feng, et al.
Published: (2023-11-01)